VitalSignum, Finland and Vendor Junction signs development agreement for market entry in Middle East, Africa, South Asia and LATAM markets. Vital Signum flagship device, Beat2phone is a simple, reliable and easy-to-use wearable electrocardiogram (ECG) sensor with a phone application connected to a cloud analytics service for fast, cost-effective screening of heart problems. Beat2Phone Point of Care (PoC) ECG is an IoT and AI based cardiac assessment medical device to screen and treat patients with cardiac abnormalities and palpitation symptoms in the basic healthcare units and primary healthcare centers instead of referring the patients to often unnecessarily, to the high cost secondary care heart hospitals and specialists.
Beat2Phone ECG is CE certified and reliable and easy-to-use wearable electrocardiogram (ECG) sensor placed on the chest and connected to a smart phone app with a cloud analytics service for fast, cost-effective screening of heart abnormalities with Real-Time Functionalities and detailed algorithmic generated detailed ECG report for treatment (Medical CE category 2A). The device can be comfortably worn by the patient for short rest and Holter ECG. The whole service entity has been designed with AI driven automation to save the healthcare entities and professionals valuable time and costs with reliable ECG assessments and reports.
Beat2Phone ECG is an ideal diagnostic tool for private sector clinics, primary care clinicians, cardiologists, neurologists and elderly home care professionals. Beat2Phone ECG enables an improved cardiac diagnostics at PoC, assessment and preventive monitoring and observation of cardiac symptoms leading to cost and time savings in the health care and a healthier life for the patients.
Cardiovascular diseases are one of the leading causes of death in the world. Approximately 10% of the global population suffers from cardiac-related symptoms such atrial fibrillation, 40% of strokes are caused by atrial fibrillation. It is estimated that the number of patients with atrial fibrillation will increase globally 250% by 2050. In the developing countries, Beat2Phone is very well positioned to address the patients limited access to cardiac diagnostics centers, medical professionals, treatment and high costs.
Balansio enters India healthcare market for diabetes monitoring and management with Vendor Junction FZC.
Finnish start-up company Quattro Folia Oy has signed a pan-India distributor agreement with Mumbai based Balansio Care (Pvt) Limited for its Balansio service. Private sector hospitals and clinics are signing up with Balansio Care for using the Balansio to extend improved monitoring and management of their patients.
Following the signing of India partnership agreement, Quattro Folia representative and management consultant, Vendor Junction FZC based in the United Arab Emirates, is now extending Balansio presence Saudi Arabia, United Arab Emirates, Pakistan and Sri Lanka in partnership with leading companies in the healthcare industry.
Balansio as software-as-a-service suites well to Indian markets as it is cost-efficient and can easily scale to the needs of India’s large and growing population with diabetes. We are delighted with the opportunity to enable better care for diabetics in India. India is a very important first step in our strategy to bring Balansio available for diabetics worldwide said Harri Okkonen, CEO of Quattro Folia
Find out more: https://lnkd.in/fpwWAyu
AMANDEL Oy has named Vendor Junction as its exclusive partner in the GCC region. Under the agreement, Vendor Junction will build the in-country distribution, reseller and retail channel network across the region in the target verticals.
AMANDEL’s flagship product, Shivers is a unique device with worldwide patented design and technical solutions. With powerful vibration motors and tailored programs, Shivers have been proven to help horses and animals to relax and rejuvenate for overall wellness.
“Partnering with Vendor Junction is a critical milestone in our Middle East market strategy,” says Jarmo Bergbacka CEO & Founder, AMANDEL Oy, “With our reach and experience in equine industry across Europe, Middle East is a very exciting and promising opportunity for us and Vendor Junction has the channel & local market knowledge to help us reach new customers in these markets and to expand our presence in the Middle East region and drive sales.”
The Federal Minister of Planning & Development – Asad Umar, chaired the signing ceremony of a historic MoU between the Kajaani University of Applied Sciences (KAMK), Allied ICT Finland (AIF) and Virtual University Pakistan (VUP) to launch an initiative to train 1 million students on disruptive technologies like; Artificial Intelligence (AI), Internet of Things (IOT), Gaming-Tech, Health-Tech, etc. This is the first and the largest ‘Mass IT Education Program’ in collaboration with a foreign university and ICT research hub in Pakistan. Dr. Khalid Maqbool Siddiqui (MNA) also graced the occasion.
Vendor Junction represents KAMK and AIF for Global Alliances and Collaboration. The CEO, Sayed Jawed witnessed the signing ceremony, along with Mr. Umair Azam, Managing Director of Integration Xperts (Vendor Junction & KAMK Representative in Pakistan). The stakeholders have been working hard for the last one year, to make this venture a reality.
Mediracer, Finland selects Vendor Junction as its business development partner for market entry in Middle East and South Asia healthcare sector. mediracer flagship device, Mediracer® NCS is a portable solution for fast, cost-effective and easy diagnostics tool for measuring sensory and motor nerve conductions for diagnosing and evaluating systemic and entrapment neuropathies. Mediracer® NCS requires only a short training to operate, and user friendly analysis software makes the examination process straightforward. From Left: Sayed Jawed (CEO, Vendor Junction), Dr. Georg Meissner (CEO, mediracer) and Jarmo Jarvenpaa (Founder & CEO, iSTOC). For more details, please visit us on www.mediracer.com and www.vendor-junction.com.